{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:16:04Z","timestamp":1772615764081,"version":"3.50.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA211732"],"award-info":[{"award-number":["R01CA211732"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA196516"],"award-info":[{"award-number":["P50CA196516"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RR190058"],"award-info":[{"award-number":["RR190058"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Metastasis is the main cause of cancer-related deaths, yet the underlying mechanisms remain elusive. Here, using clear cell renal cell carcinoma (ccRCC), a tumor type with frequent lung metastases, we conduct an in vivo genome-wide CRISPR-Cas9 screen and identify HLF as a potent suppressor of lung metastasis. <jats:italic>HLF<\/jats:italic> depletion enhances ccRCC cell migration and lung metastasis, whereas <jats:italic>HLF<\/jats:italic> overexpression abrogates these effects. In ccRCC patients, <jats:italic>HLF<\/jats:italic> expression is reduced at metastatic sites and associates with epigenetic silencing mediated by the SWI\/SNF ATPase subunit BRG1. <jats:italic>HLF<\/jats:italic> levels negatively correlate with migration potential in collagen. Mechanistically, HLF regulates <jats:italic>LPXN<\/jats:italic> expression, modulating the integration of collagen\u2019s mechanical cues with the actin cytoskeleton through Paxillin, thereby suppressing cancer cell migration and lung metastasis. Overexpression of <jats:italic>HLF<\/jats:italic> or pharmacological inhibition of BRG1 reduces cell invasion across multiple cancer types. Our findings suggest that targeting the BRG1-HLF axis offers a promising therapeutic strategy for combating metastatic cancers.<\/jats:p>","DOI":"10.1038\/s41467-025-60329-9","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:54:32Z","timestamp":1749124472000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SWI\/SNF ATPase silenced HLF potentiates lung metastasis in solid cancers"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0100-1983","authenticated-orcid":false,"given":"Jin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-2001","authenticated-orcid":false,"given":"Austin","family":"Hepperla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-1663","authenticated-orcid":false,"given":"Jeremy M.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangsan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3349-0056","authenticated-orcid":false,"given":"Qing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanhai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9574-0148","authenticated-orcid":false,"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5600-5634","authenticated-orcid":false,"given":"Lianxin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9073-3835","authenticated-orcid":false,"given":"Chengheng","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yayoi","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangzhou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8946-7069","authenticated-orcid":false,"given":"Peter","family":"Ly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0441-0747","authenticated-orcid":false,"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4239-0495","authenticated-orcid":false,"given":"Payal","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5815-4457","authenticated-orcid":false,"given":"Lin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwei","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0829-2365","authenticated-orcid":false,"given":"Srinivas","family":"Malladi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8575-499X","authenticated-orcid":false,"given":"James","family":"Brugarolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9106-447X","authenticated-orcid":false,"given":"M. Celeste","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-8339","authenticated-orcid":false,"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6595-8995","authenticated-orcid":false,"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"60329_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"S Valastyan","year":"2011","unstructured":"Valastyan, S. & Weinberg, R. A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147, 275\u2013292 (2011).","journal-title":"Cell"},{"key":"60329_CR2","doi-asserted-by":"publisher","first-page":"e2021869","DOI":"10.1001\/jamanetworkopen.2020.21869","volume":"4","author":"S Dudani","year":"2021","unstructured":"Dudani, S. et al. Evaluation of Clear Cell, Papillary, and Chromophobe Renal Cell Carcinoma Metastasis Sites and Association With Survival. JAMA Netw. Open 4, e2021869 (2021).","journal-title":"JAMA Netw. Open"},{"key":"60329_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016684","volume":"98","author":"X Feng","year":"2019","unstructured":"Feng, X., Zhang, L., Tu, W. & Cang, S. Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis. Med. (Baltim.) 98, e16684 (2019).","journal-title":"Med. (Baltim.)"},{"key":"60329_CR4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1097\/01.ju.0000177487.64651.3a","volume":"174","author":"BC Leibovich","year":"2005","unstructured":"Leibovich, B. C. et al. A scoring algorithm to predict survival for patients with metastatic clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. J. Urol. 174, 1759\u20131763 (2005). discussion 1763.","journal-title":"J. Urol."},{"key":"60329_CR5","doi-asserted-by":"publisher","first-page":"115390","DOI":"10.1016\/j.biopha.2023.115390","volume":"166","author":"Q Zhang","year":"2023","unstructured":"Zhang, Q., An, Z. Y., Jiang, W., Jin, W. L. & He, X. Y. Collagen code in tumor microenvironment: Functions, molecular mechanisms, and therapeutic implications. Biomed. Pharmacother. 166, 115390 (2023).","journal-title":"Biomed. Pharmacother."},{"key":"60329_CR6","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1091\/mbc.E18-05-0319","volume":"29","author":"L Wullkopf","year":"2018","unstructured":"Wullkopf, L. et al. Cancer cells\u2019 ability to mechanically adjust to extracellular matrix stiffness correlates with their invasive potential. Mol. Biol. Cell 29, 2378\u20132385 (2018).","journal-title":"Mol. Biol. Cell"},{"key":"60329_CR7","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.taap.2013.01.031","volume":"268","author":"KM Waters","year":"2013","unstructured":"Waters, K. M., Sontag, R. L. & Weber, T. J. Hepatic leukemia factor promotes resistance to cell death: implications for therapeutics and chronotherapy. Toxicol. Appl Pharm. 268, 141\u2013148 (2013).","journal-title":"Toxicol. Appl Pharm."},{"key":"60329_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.ccell.2019.10.004","volume":"36","author":"Y Huang","year":"2019","unstructured":"Huang, Y. et al. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell 36, 630\u2013644.e639 (2019).","journal-title":"Cancer Cell"},{"key":"60329_CR9","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1182\/blood.V92.4.1397","volume":"92","author":"RA Altura","year":"1998","unstructured":"Altura, R. A. et al. The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells. Blood 92, 1397\u20131405 (1998).","journal-title":"Blood"},{"key":"60329_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/leu.2010.253","volume":"25","author":"J de Boer","year":"2011","unstructured":"de Boer, J. et al. The E2A-HLF oncogenic fusion protein acts through Lmo2 and Bcl-2 to immortalize hematopoietic progenitors. Leukemia 25, 321\u2013330 (2011).","journal-title":"Leukemia"},{"key":"60329_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.cancergen.2012.10.004","volume":"205","author":"I Panagopoulos","year":"2012","unstructured":"Panagopoulos, I. et al. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13). Cancer Genet 205, 669\u2013672 (2012).","journal-title":"Cancer Genet"},{"key":"60329_CR12","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1136\/gutjnl-2018-317440","volume":"68","author":"DM Xiang","year":"2019","unstructured":"Xiang, D. M. et al. Oncofetal HLF transactivates c-Jun to promote hepatocellular carcinoma development and sorafenib resistance. Gut 68, 1858\u20131871 (2019).","journal-title":"Gut"},{"key":"60329_CR13","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2020.04.007","volume":"482","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR\/NF-kappab signaling. Cancer Lett. 482, 56\u201371 (2020).","journal-title":"Cancer Lett."},{"key":"60329_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06076-5","volume":"14","author":"T Han","year":"2023","unstructured":"Han, T. et al. HLF promotes ovarian cancer progression and chemoresistance via regulating Hippo signaling pathway. Cell Death Dis. 14, 606 (2023).","journal-title":"Cell Death Dis."},{"key":"60329_CR15","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","volume":"601","author":"L Xiao","year":"2022","unstructured":"Xiao, L. et al. Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer. Nature 601, 434\u2013439 (2022).","journal-title":"Nature"},{"key":"60329_CR16","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1002\/ijc.33701","volume":"149","author":"MP Purdue","year":"2021","unstructured":"Purdue, M. P. et al. Differences in risk factors for molecular subtypes of clear cell renal cell carcinoma. Int J. Cancer 149, 1448\u20131454 (2021).","journal-title":"Int J. Cancer"},{"key":"60329_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25918-4","volume":"12","author":"K Kim","year":"2021","unstructured":"Kim, K. et al. Determinants of renal cell carcinoma invasion and metastatic competence. Nat. Commun. 12, 5760 (2021).","journal-title":"Nat. Commun."},{"key":"60329_CR18","doi-asserted-by":"crossref","unstructured":"Bartha, A. & Gyorffy, B. TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int. J. Mol. Sci. 22, 2622 (2021).","DOI":"10.3390\/ijms22052622"},{"key":"60329_CR19","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.3390\/ijms150915011","volume":"15","author":"X Gai","year":"2014","unstructured":"Gai, X., Tu, K., Lu, Z. & Zheng, X. MRC2 expression correlates with TGFbeta1 and survival in hepatocellular carcinoma. Int J. Mol. Sci. 15, 15011\u201315025 (2014).","journal-title":"Int J. Mol. Sci."},{"key":"60329_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152553","volume":"215","author":"ZH Yu","year":"2019","unstructured":"Yu, Z. H. et al. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer. Pathol. Res Pr. 215, 152553 (2019).","journal-title":"Pathol. Res Pr."},{"key":"60329_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.4049\/jimmunol.2101048","volume":"211","author":"C Liu","year":"2023","unstructured":"Liu, C. et al. G Protein-Coupled Receptor 56 Characterizes CTLs and Reflects the Progression of Lung Cancer Patients. J. Immunol. 211, 683\u2013692 (2023).","journal-title":"J. Immunol."},{"key":"60329_CR22","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.3892\/mmr.2016.5580","volume":"14","author":"C Huang","year":"2016","unstructured":"Huang, C. et al. Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma. Mol. Med Rep. 14, 2489\u20132496 (2016).","journal-title":"Mol. Med Rep."},{"key":"60329_CR23","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/cas.14257","volume":"111","author":"T Ando","year":"2020","unstructured":"Ando, T. et al. Integrin alpha11 in non-small cell lung cancer is associated with tumor progression and postoperative recurrence. Cancer Sci. 111, 200\u2013208 (2020).","journal-title":"Cancer Sci."},{"key":"60329_CR24","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejphar.2019.02.041","volume":"851","author":"PW Wang","year":"2019","unstructured":"Wang, P. W., Yang, Q. B., Du, X. Y., Chen, Y. & Zhang, T. Targeted regulation of Rell2 by microRNA-18a is implicated in the anti-metastatic effect of polyphyllin VI in breast cancer cells. Eur. J. Pharm. 851, 161\u2013173 (2019).","journal-title":"Eur. J. Pharm."},{"key":"60329_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1158\/2159-8290.CD-22-0236","volume":"13","author":"K Kim","year":"2023","unstructured":"Kim, K. et al. Cell Competition Shapes Metastatic Latency and Relapse. Cancer Discov. 13, 85\u201397 (2023).","journal-title":"Cancer Discov."},{"key":"60329_CR26","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1136\/gutjnl-2016-313392","volume":"67","author":"DM Xiang","year":"2018","unstructured":"Xiang, D. M. et al. The HLF\/IL-6\/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosis. Gut 67, 1704\u20131715 (2018).","journal-title":"Gut"},{"key":"60329_CR27","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.molcel.2022.06.003","volume":"82","author":"J Zhou","year":"2022","unstructured":"Zhou, J. et al. An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. Mol. Cell 82, 3030\u20133044 e3038 (2022).","journal-title":"Mol. Cell"},{"key":"60329_CR28","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1158\/2159-8290.CD-17-0375","volume":"7","author":"X Yao","year":"2017","unstructured":"Yao, X. et al. VHL Deficiency Drives Enhancer Activation of Oncogenes in Clear Cell Renal Cell Carcinoma. Cancer Discov. 7, 1284\u20131305 (2017).","journal-title":"Cancer Discov."},{"key":"60329_CR29","doi-asserted-by":"publisher","first-page":"21931","DOI":"10.1073\/pnas.1016071107","volume":"107","author":"MP Creyghton","year":"2010","unstructured":"Creyghton, M. P. et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931\u201321936 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"60329_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95398-5","volume":"11","author":"W Zhao","year":"2021","unstructured":"Zhao, W. et al. Investigating crosstalk between H3K27 acetylation and H3K4 trimethylation in CRISPR\/dCas-based epigenome editing and gene activation. Sci. Rep. 11, 15912 (2021).","journal-title":"Sci. Rep."},{"key":"60329_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14362-5","volume":"11","author":"K Li","year":"2020","unstructured":"Li, K. et al. Interrogation of enhancer function by enhancer-targeting CRISPR epigenetic editing. Nat. Commun. 11, 485 (2020).","journal-title":"Nat. Commun."},{"key":"60329_CR32","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/j.1349-7006.2009.01398.x","volume":"101","author":"T Tanaka","year":"2010","unstructured":"Tanaka, T., Moriwaki, K., Murata, S. & Miyasaka, M. LIM domain-containing adaptor, leupaxin, localizes in focal adhesion and suppresses the integrin-induced tyrosine phosphorylation of paxillin. Cancer Sci. 101, 363\u2013368 (2010).","journal-title":"Cancer Sci."},{"key":"60329_CR33","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1242\/jcs.018044","volume":"121","author":"NO Deakin","year":"2008","unstructured":"Deakin, N. O. & Turner, C. E. Paxillin comes of age. J. Cell Sci. 121, 2435\u20132444 (2008).","journal-title":"J. Cell Sci."},{"key":"60329_CR34","first-page":"364","volume":"7","author":"Y Guo","year":"2022","unstructured":"Guo, Y. et al. Matrix stiffness modulates tip cell formation through the p-PXN-Rac1-YAP signaling axis. Bioact. Mater. 7, 364\u2013376 (2022).","journal-title":"Bioact. Mater."},{"key":"60329_CR35","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/s41586-020-1998-1","volume":"578","author":"JS Park","year":"2020","unstructured":"Park, J. S. et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature 578, 621\u2013626 (2020).","journal-title":"Nature"},{"key":"60329_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.ircmb.2020.05.003","volume":"355","author":"KM Alpha","year":"2020","unstructured":"Alpha, K. M., Xu, W. & Turner, C. E. Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion. Int Rev. Cell Mol. Biol. 355, 1\u201352 (2020).","journal-title":"Int Rev. Cell Mol. Biol."},{"key":"60329_CR37","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nm.3029","volume":"19","author":"S Vanharanta","year":"2013","unstructured":"Vanharanta, S. et al. Epigenetic expansion of VHL-HIF signal output drives multiorgan metastasis in renal cancer. Nat. Med. 19, 50\u201356 (2013).","journal-title":"Nat. Med."},{"key":"60329_CR38","doi-asserted-by":"crossref","unstructured":"Zou, Z., Ohta, T. & Oki, S. ChIP-Atlas 3.0: a data-mining suite to explore chromosome architecture together with large-scale regulome data. Nucleic Acids Res 52, W45\u2013W53 (2024).","DOI":"10.1093\/nar\/gkae358"},{"key":"60329_CR39","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature19796","volume":"539","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539, 112\u2013117 (2016).","journal-title":"Nature"},{"key":"60329_CR40","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1021\/acs.nanolett.2c01327","volume":"22","author":"L Sikic","year":"2022","unstructured":"Sikic, L. et al. Nanoscale Tracking Combined with Cell-Scale Microrheology Reveals Stepwise Increases in Force Generated by Cancer Cell Protrusions. Nano Lett. 22, 7742\u20137750 (2022).","journal-title":"Nano Lett."},{"key":"60329_CR41","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.tcb.2018.06.003","volume":"28","author":"PT Caswell","year":"2018","unstructured":"Caswell, P. T. & Zech, T. Actin-Based Cell Protrusion in a 3D Matrix. Trends Cell Biol. 28, 823\u2013834 (2018).","journal-title":"Trends Cell Biol."},{"key":"60329_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","volume":"22","author":"JS You","year":"2012","unstructured":"You, J. S. & Jones, P. A. Cancer genetics and epigenetics: two sides of the same coin?. Cancer Cell 22, 9\u201320 (2012).","journal-title":"Cancer Cell"},{"key":"60329_CR43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature14347","volume":"520","author":"G Gundem","year":"2015","unstructured":"Gundem, G. et al. The evolutionary history of lethal metastatic prostate cancer. Nature 520, 353\u2013357 (2015).","journal-title":"Nature"},{"key":"60329_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","volume":"618","author":"F Martinez-Jimenez","year":"2023","unstructured":"Martinez-Jimenez, F. et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature 618, 333\u2013341 (2023).","journal-title":"Nature"},{"key":"60329_CR45","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.trecan.2021.11.008","volume":"8","author":"R Banerjee","year":"2022","unstructured":"Banerjee, R., Smith, J., Eccles, M. R., Weeks, R. J. & Chatterjee, A. Epigenetic basis and targeting of cancer metastasis. Trends Cancer 8, 226\u2013241 (2022).","journal-title":"Trends Cancer"},{"key":"60329_CR46","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.3390\/ijms22115561","volume":"22","author":"SE Lee","year":"2021","unstructured":"Lee, S. E., Park, H. Y., Hwang, D. Y. & Han, H. S. High Concordance of Genomic Profiles between Primary and Metastatic Colorectal Cancer. Int J. Mol. Sci. 22, 5561 (2021).","journal-title":"Int J. Mol. Sci."},{"key":"60329_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24813-2","volume":"12","author":"B Ye","year":"2021","unstructured":"Ye, B. et al. Oncogenic enhancers drive esophageal squamous cell carcinogenesis and metastasis. Nat. Commun. 12, 4457 (2021).","journal-title":"Nat. Commun."},{"key":"60329_CR48","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nm.4475","volume":"24","author":"JJ Morrow","year":"2018","unstructured":"Morrow, J. J. et al. Positively selected enhancer elements endow osteosarcoma cells with metastatic competence. Nat. Med. 24, 176\u2013185 (2018).","journal-title":"Nat. Med."},{"key":"60329_CR49","doi-asserted-by":"crossref","unstructured":"Liu, X. L., Duan, Z., Yu, M. & Liu, X. Epigenetic control of circadian clocks by environmental signals. Trends Cell Biol 34, 992\u20131006 (2024).","DOI":"10.1016\/j.tcb.2024.02.005"},{"key":"60329_CR50","doi-asserted-by":"crossref","unstructured":"Sapna, P. P. et al. A Phase 1 Dose Escalation and Expansion Study of FHD-286, a Novel BRG1\/BRM (SMARCA4\/SMARCA2) Inhibitor, for the Treatment of Metastatic Uveal Melanoma. Ann. Oncol. 34, S677\u2013S678 (2023).","DOI":"10.1016\/j.annonc.2023.09.2262"},{"key":"60329_CR51","doi-asserted-by":"crossref","unstructured":"DiNardo, C. D. et al. Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1\/BRM (SMARCA4\/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies. Blood 142, 4284 (2023).","DOI":"10.1182\/blood-2023-178090"},{"key":"60329_CR52","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/mutage\/gead027","volume":"38","author":"H Zhou","year":"2023","unstructured":"Zhou, H. & Wang, F. Tensin 1 regulated by hepatic leukemia factor represses the progression of prostate cancer. Mutagenesis 38, 295\u2013304 (2023).","journal-title":"Mutagenesis"},{"key":"60329_CR53","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.18632\/oncotarget.24192","volume":"9","author":"C Liu","year":"2018","unstructured":"Liu, C. et al. c-Jun-dependent beta3GnT8 promotes tumorigenesis and metastasis of hepatocellular carcinoma by inducing CD147 glycosylation and altering N-glycan patterns. Oncotarget 9, 18327\u201318340 (2018).","journal-title":"Oncotarget"},{"key":"60329_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.225","volume":"7","author":"Y Peng","year":"2016","unstructured":"Peng, Y. et al. Direct regulation of FOXK1 by C-jun promotes proliferation, invasion and metastasis in gastric cancer cells. Cell Death Dis. 7, e2480 (2016).","journal-title":"Cell Death Dis."},{"key":"60329_CR55","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.cell.2015.02.038","volume":"160","author":"S Chen","year":"2015","unstructured":"Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246\u20131260 (2015).","journal-title":"Cell"},{"key":"60329_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"60329_CR57","doi-asserted-by":"publisher","first-page":"e0279336","DOI":"10.1371\/journal.pone.0279336","volume":"18","author":"L Hauke","year":"2023","unstructured":"Hauke, L. et al. FilamentSensor 2.0: An open-source modular toolbox for 2D\/3D cytoskeletal filament tracking. PLoS One 18, e0279336 (2023).","journal-title":"PLoS One"},{"key":"60329_CR58","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.molcel.2020.01.009","volume":"77","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Genome-wide Screening Identifies SFMBT1 as an Oncogenic Driver in Cancer with VHL Loss. Mol. Cell 77, 1294\u20131306 e1295 (2020).","journal-title":"Mol. Cell"},{"key":"60329_CR59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1158\/2159-8290.CD-17-1211","volume":"8","author":"P Rodrigues","year":"2018","unstructured":"Rodrigues, P. et al. NF-kappaB-Dependent Lymphoid Enhancer Co-option Promotes Renal Carcinoma Metastasis. Cancer Discov. 8, 850\u2013865 (2018).","journal-title":"Cancer Discov."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60329-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60329-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:02:43Z","timestamp":1749128563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-60329-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,5]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["60329"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-60329-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,5]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Qing Zhang received the consultation fee from Exelixis. Other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5226"}}